SURF-1 Antibodies

Santa Cruz Biotechnology delivers a wide array of SURF-1 monoclonal antibodies for investigating SURF-1's role in cellular processes. SURF-1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SURF-1, or Surfeit 1, is a protein that plays a critical role in mitochondrial function and energy metabolism. SURF-1 is involved in the regulation of cytochrome c oxidase assembly, which is essential for the electron transport chain and ATP production. Mutations in SURF-1 have been linked to various mitochondrial disorders, particularly Leigh syndrome, a severe neurological condition. Understanding SURF-1's function is crucial for developing therapeutic strategies for mitochondrial diseases. Research into SURF-1 continues to reveal new insights about cellular energy production and mitochondrial maintenance. SURF-1 studies have significant implications for both fundamental research and clinical applications. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of mitochondrial biology and disease mechanisms.